Compass Minerals International Inc. press release
Compumedics expects to be back in profit for FY23
NYSE - New York Stock Exchange · Salt · Potash · Magnesium · United States
(NewsDirect)
Compumedics Ltd (ASX:CMP) CFO David Lawson tells Proactive the company has strengthened its sales figures to $4.3 million, after receiving orders from China which are back to pre-pandemic levels. In addition, the company had also booked a $700,000 sales order to supply, among other items, its new Okti® neurological monitoring system to the Royal Children’s Hospital in Melbourne.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.